First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Soria, Jean-Charles, Prof, Tan, Daniel S W, MD, Chiari, Rita, MD, Wu, Yi-Long, Prof, Paz-Ares, Luis, Prof, Wolf, Juergen, Prof, Geater, Sarayut L, MD, Orlov, Sergey, Prof, Cortinovis, Diego, MD, Yu, Chong-Jen, Prof, Hochmair, Maximillian, MD, Cortot, Alexis B, Prof, Tsai, Chun-Ming, Prof, Moro-Sibilot, Denis, MD, Campelo, Rosario G, MD, McCulloch, Tracey, MSc, Sen, Paramita, PhD, Dugan, Margaret, MD, Pantano, Serafino, PhD, Branle, Fabrice, MD, Massacesi, Cristian, MD, de Castro, Gilberto, MD
Published in The Lancet (British edition) (04.03.2017)
Published in The Lancet (British edition) (04.03.2017)
Get full text
Journal Article